Recently, we have also shown that RNA toxicity activates both the classical (canonical) and alternate (non-canonical) NF-κB pathways in mice and individuals with DM1, and that the Fn14 deficiency modulates these effects [9]. The gene discussed is TNFRSF12A; the disease is myotonic dystrophy type 1.